通策医疗股价涨5.19%,华宝基金旗下1只基金位居十大流通股东,持有888.54万股浮盈赚取2043.63万元

Group 1 - The core viewpoint of the news is that Tongce Medical's stock has seen a significant increase of 5.19%, reaching a price of 46.60 yuan per share, with a trading volume of 570 million yuan and a turnover rate of 2.80%, resulting in a total market capitalization of 20.844 billion yuan [1] - Tongce Medical Co., Ltd. is located in Hangzhou, established on August 30, 1995, and listed on October 30, 1996. The company's main business involves medical service investment and dental medical services [1] - The revenue composition of Tongce Medical is as follows: medical services account for 92.84%, product sales 4.06%, construction engineering 2.72%, and others 0.38% [1] Group 2 - From the perspective of the top ten circulating shareholders of Tongce Medical, Huabao Fund's ETF, Huabao Zhongzheng Medical ETF (512170), reduced its holdings by 1.5804 million shares in the third quarter, now holding 8.8854 million shares, which represents 1.99% of the circulating shares [2] - The Huabao Zhongzheng Medical ETF (512170) was established on May 20, 2019, with a latest scale of 26.404 billion yuan. Year-to-date returns are 7.98%, ranking 1481 out of 5542 in its category; the one-year return is 16.76%, ranking 3551 out of 4243; and since inception, the return is 9.93% [2] - The fund manager of Huabao Zhongzheng Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 101 days, with total fund assets of 100.204 billion yuan. The best fund return during his tenure is 165.65%, while the worst is -98.01% [2]